 Margret Bock
Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 11 | 2024 | 708 | 2.930 |
Why?
| | Tacrolimus | 3 | 2024 | 199 | 1.820 |
Why?
| | Immunosuppressive Agents | 6 | 2024 | 890 | 1.610 |
Why?
| | Organ Transplantation | 2 | 2024 | 250 | 1.250 |
Why?
| | Renal Insufficiency | 4 | 2025 | 162 | 1.080 |
Why?
| | Graft Survival | 4 | 2024 | 535 | 1.020 |
Why?
| | Kidney Failure, Chronic | 5 | 2023 | 570 | 0.970 |
Why?
| | Transplant Recipients | 3 | 2024 | 184 | 0.950 |
Why?
| | Glomerular Filtration Rate | 7 | 2024 | 746 | 0.910 |
Why?
| | Nephritis, Interstitial | 1 | 2024 | 14 | 0.870 |
Why?
| | Delayed-Action Preparations | 1 | 2024 | 181 | 0.830 |
Why?
| | Graft Rejection | 2 | 2024 | 624 | 0.790 |
Why?
| | Transition to Adult Care | 1 | 2021 | 91 | 0.620 |
Why?
| | Nephrotic Syndrome | 2 | 2024 | 39 | 0.620 |
Why?
| | Glomerulosclerosis, Focal Segmental | 2 | 2024 | 47 | 0.610 |
Why?
| | Postoperative Complications | 4 | 2024 | 2654 | 0.600 |
Why?
| | Thrombophilia | 1 | 2018 | 83 | 0.580 |
Why?
| | Dyslipidemias | 1 | 2020 | 176 | 0.570 |
Why?
| | HLA Antigens | 1 | 2019 | 240 | 0.560 |
Why?
| | Antibodies | 1 | 2019 | 410 | 0.530 |
Why?
| | Tissue Donors | 2 | 2019 | 425 | 0.520 |
Why?
| | Preoperative Care | 1 | 2018 | 362 | 0.500 |
Why?
| | Thrombosis | 1 | 2018 | 371 | 0.450 |
Why?
| | Receptors, Urokinase Plasminogen Activator | 1 | 2013 | 15 | 0.410 |
Why?
| | Retrospective Studies | 11 | 2025 | 15657 | 0.360 |
Why?
| | Adolescent | 12 | 2024 | 21513 | 0.340 |
Why?
| | Child | 14 | 2024 | 21935 | 0.310 |
Why?
| | Risk Factors | 7 | 2024 | 10388 | 0.300 |
Why?
| | Heart Transplantation | 2 | 2024 | 754 | 0.280 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2111 | 0.270 |
Why?
| | Young Adult | 6 | 2024 | 13209 | 0.260 |
Why?
| | Follow-Up Studies | 3 | 2024 | 5131 | 0.220 |
Why?
| | Bartter Syndrome | 1 | 2023 | 8 | 0.220 |
Why?
| | Polyhydramnios | 1 | 2023 | 17 | 0.220 |
Why?
| | Humans | 22 | 2025 | 137585 | 0.210 |
Why?
| | Kidney Function Tests | 1 | 2024 | 160 | 0.210 |
Why?
| | Calcineurin Inhibitors | 1 | 2024 | 72 | 0.210 |
Why?
| | Treatment Outcome | 7 | 2025 | 10811 | 0.210 |
Why?
| | Infant | 5 | 2022 | 9465 | 0.210 |
Why?
| | Viremia | 1 | 2024 | 138 | 0.200 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 105 | 0.200 |
Why?
| | Child, Preschool | 5 | 2024 | 11074 | 0.200 |
Why?
| | Urethral Obstruction | 1 | 2022 | 9 | 0.190 |
Why?
| | Urethral Diseases | 1 | 2022 | 19 | 0.190 |
Why?
| | Urinary Tract | 1 | 2022 | 51 | 0.180 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2025 | 301 | 0.180 |
Why?
| | Female | 13 | 2025 | 73304 | 0.180 |
Why?
| | Male | 11 | 2025 | 67762 | 0.180 |
Why?
| | Recurrence | 1 | 2024 | 1060 | 0.170 |
Why?
| | Fetal Diseases | 1 | 2022 | 173 | 0.170 |
Why?
| | Premature Birth | 1 | 2023 | 333 | 0.160 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2024 | 617 | 0.160 |
Why?
| | Histocompatibility Testing | 1 | 2019 | 126 | 0.150 |
Why?
| | Administration, Oral | 1 | 2021 | 816 | 0.150 |
Why?
| | Remission Induction | 2 | 2024 | 288 | 0.150 |
Why?
| | Mycophenolic Acid | 1 | 2019 | 117 | 0.150 |
Why?
| | Medication Adherence | 1 | 2021 | 467 | 0.130 |
Why?
| | Decision Making | 1 | 2023 | 900 | 0.130 |
Why?
| | Prognosis | 1 | 2024 | 4030 | 0.120 |
Why?
| | Kidney | 3 | 2023 | 1468 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 5472 | 0.120 |
Why?
| | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2015 | 23 | 0.110 |
Why?
| | Liver Transplantation | 1 | 2022 | 871 | 0.110 |
Why?
| | Glomerulonephritis | 1 | 2015 | 47 | 0.110 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 815 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2019 | 622 | 0.100 |
Why?
| | Proteinuria | 1 | 2013 | 97 | 0.100 |
Why?
| | Prevalence | 1 | 2019 | 2734 | 0.090 |
Why?
| | Renal Replacement Therapy | 2 | 2022 | 92 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2019 | 1069 | 0.090 |
Why?
| | Adult | 3 | 2024 | 37929 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2057 | 0.070 |
Why?
| | Infant, Newborn | 3 | 2025 | 6079 | 0.070 |
Why?
| | Survival Analysis | 1 | 2010 | 1325 | 0.070 |
Why?
| | Time Factors | 2 | 2015 | 6828 | 0.060 |
Why?
| | Fetal Death | 1 | 2023 | 55 | 0.050 |
Why?
| | Dissent and Disputes | 1 | 2023 | 20 | 0.050 |
Why?
| | Registries | 2 | 2022 | 2035 | 0.050 |
Why?
| | Cohort Studies | 1 | 2013 | 5742 | 0.050 |
Why?
| | Patient Care | 1 | 2023 | 111 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 319 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 430 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 6763 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2022 | 285 | 0.040 |
Why?
| | Logistic Models | 1 | 2024 | 2074 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2022 | 435 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2844 | 0.030 |
Why?
| | Critical Illness | 1 | 2022 | 811 | 0.030 |
Why?
| | Perioperative Care | 1 | 2017 | 178 | 0.030 |
Why?
| | Chicago | 1 | 2015 | 61 | 0.030 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2015 | 36 | 0.030 |
Why?
| | Parents | 1 | 2023 | 1347 | 0.030 |
Why?
| | Cyclophosphamide | 1 | 2015 | 247 | 0.030 |
Why?
| | Rituximab | 1 | 2015 | 176 | 0.030 |
Why?
| | Patient Selection | 1 | 2017 | 696 | 0.030 |
Why?
| | Biopsy | 1 | 2015 | 1129 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 565 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2031 | 0.020 |
Why?
| | United States | 1 | 2024 | 14841 | 0.020 |
Why?
| | Biomarkers | 1 | 2015 | 4149 | 0.010 |
Why?
|
|
Bock's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|